Teachers Advisors LLC purchased a new stake in Sientra, Inc. (NASDAQ:SIEN) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 25,376 shares of the medical instruments supplier’s stock, valued at approximately $247,000. Teachers Advisors LLC owned about 0.13% of Sientra at the end of the most recent reporting period.
A number of other hedge funds have also added to or reduced their stakes in the stock. Wells Fargo & Company MN raised its position in Sientra by 0.3% in the 1st quarter. Wells Fargo & Company MN now owns 12,871 shares of the medical instruments supplier’s stock valued at $108,000 after purchasing an additional 40 shares during the last quarter. Bank of New York Mellon Corp increased its stake in Sientra by 0.5% in the 1st quarter. Bank of New York Mellon Corp now owns 51,760 shares of the medical instruments supplier’s stock valued at $436,000 after buying an additional 250 shares during the period. Parametric Portfolio Associates LLC increased its stake in Sientra by 14.4% in the 1st quarter. Parametric Portfolio Associates LLC now owns 16,410 shares of the medical instruments supplier’s stock valued at $138,000 after buying an additional 2,065 shares during the period. JPMorgan Chase & Co. acquired a new position in Sientra in the 2nd quarter valued at $101,000. Finally, Accredited Investors Inc. acquired a new position in Sientra in the 2nd quarter valued at $115,000. Hedge funds and other institutional investors own 78.62% of the company’s stock.
Several equities analysts have issued reports on SIEN shares. William Blair raised shares of Sientra from a “market perform” rating to an “outperform” rating in a research note on Wednesday, September 13th. Lake Street Capital reissued a “buy” rating and issued a $15.00 price objective (up from $11.00) on shares of Sientra in a research note on Wednesday, August 2nd. Canaccord Genuity started coverage on shares of Sientra in a research note on Monday, August 28th. They issued a “buy” rating and a $14.00 price objective on the stock. Stifel Nicolaus reissued a “hold” rating and issued a $14.00 price objective (up from $11.00) on shares of Sientra in a research note on Wednesday, September 27th. Finally, Zacks Investment Research cut shares of Sientra from a “hold” rating to a “sell” rating in a research note on Tuesday, August 15th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the stock. Sientra currently has a consensus rating of “Hold” and an average price target of $13.75.
WARNING: This piece was originally published by Markets Daily and is owned by of Markets Daily. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The correct version of this piece can be read at https://www.themarketsdaily.com/2017/11/21/teachers-advisors-llc-purchases-shares-of-25376-sientra-inc-sien.html.
Sientra (NASDAQ:SIEN) last posted its quarterly earnings results on Tuesday, November 7th. The medical instruments supplier reported ($0.74) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.68) by ($0.06). Sientra had a negative return on equity of 68.82% and a negative net margin of 169.77%. The company had revenue of $9.80 million for the quarter, compared to analyst estimates of $10.54 million. During the same period last year, the company earned ($0.55) earnings per share. The business’s revenue for the quarter was up 50.8% compared to the same quarter last year. equities research analysts forecast that Sientra, Inc. will post -3.14 earnings per share for the current year.
Sientra Company Profile
Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.
Receive News & Ratings for Sientra Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra Inc. and related companies with MarketBeat.com's FREE daily email newsletter.